San Antonio

San Antonio, Texas 78258

1 studies enrolling now · 21 studies all time

What they study most

C. Diff, C. Difficile, CDI, Cirrhosis, Clostridium Difficile Infection, Clostridium Difficile Infection Recurrence, Contraception, Dry Eye Disease (DED), Endometriosis, Endometriosis Related Pain, FMT, Fecal Microbiota

Studies at this site

• A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis — Recruiting now
• A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis — Running, not enrolling
• A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma — Completed
• Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy — Completed
• A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis — Completed
• 12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients — Stopped early
• Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids — Completed
• Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD — Stopped early
• LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids — Completed
• A Study to Evaluate TRS01 Eye Drops in Participants With Active Non-infectious Anterior Uveitis — Completed
• SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain — Completed
• Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff — Completed
• Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection — Completed
• LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids — Completed
• LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids — Completed
• Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension — Completed
• A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer — Completed
• Evaluation of the Efficacy and Safety of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease — Completed
• SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain — Completed
• Bone Mineral Density in Women With Uterine Fibroids or Endometriosis — Completed
• Staining in a Healthy, Non-Dry Eye Population — Completed